| Surgical Treatment |
Close/dirty margin, primary mastectomy |
Close/dirty margin, breast conservation |
P value chi square test |
Complete mastectomy |
Mastectomy total |
| Extensive disease |
|
|
|
|
|
| Unifocal invasive cancer without multifocal or diffuse insitucomponent |
0% (0/11) |
14.3% (1/7) |
p=0.8331 |
1 |
66.7% (12/18) |
| Unifocal invasive cancer with multifocal or diffuse insitucomponent |
10.5% (2/19) |
43.7% (38/87) |
p=0.0154 |
12 |
29.2% (31/106) |
| Multifocal invasive cancer, any insitucomponent |
17.1% (6/35) |
47.8% (22/46) |
p=0.0076 |
16 |
63% (51/81) |
| Diffuse invasive cancer, any insitucomponent |
8.3% (1/12) |
28.6% (2/7) |
p=0.5758 |
1 |
68.4% (13/19) |
| Total |
11.7% (9/76) |
42.5% (63/148) |
p <0.0001 |
30 |
47.8% (107/224) |
| Non-extensive disease |
|
|
|
|
|
| Unifocal invasive cancer without multifocal or diffuse insitucomponent |
1.4% (1/74) |
3.6% (12/337) |
p=0.3537 |
5 |
19.2% (79/411) |
| Unifocal invasive cancer with multifocal or diffuse insitucomponent |
0% (0/11) |
14.8% (8/54) |
p=0.3831 |
4 |
23.1% (15/65) |
| Multifocal invasive cancer, any insitucomponent |
9.1% (1/11) |
16.7% (9/54) |
p=0.8333 |
4 |
23.1% (15/65) |
| Diffuse invasive cancer, any insitucomponent |
0% (0/3) |
0% (0/5) |
- |
0 |
37.5% (3/8) |
| Total |
2% (2/99) |
6.4% (29/450) |
p=0.1728 |
13 |
20.4% (112/549) |
